PreciseDx: Funding, Investors & Team (Aug 2026)
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by analyzing morphology features. This allows for more tailored treatment and improved outcomes for patients. Clinical teams can trust PreciseDx for valuable insights and practical information to guide treatment choices. By utilizing artificial intelligence and its Morphology Feature Array™, PreciseDx designs disease-specific tests that provide in-depth pathology information and risk profiles for patients, aiding in treatment decisions.
PreciseDx has raised $31.9M across 2 funding rounds on record, the most recent a Series B of $11.2M announced in Jun 2025.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
PreciseDx Company Profile and Key Stats
Latest funding round on record: Jun 2025.
PreciseDx Funding Rounds
PreciseDx raised $20.7M in a Series B announced in Aug 2024.
10 months later, a Series B of $11.2M was announced in Jun 2025.
PreciseDx Founders and Leadership Team
Contact details for the PreciseDx team: 1 of 2 have an email address on file.
Start 14-day free trial →PreciseDx Funding Compared to Other Health Care Startups
PreciseDx's latest round of $11.2M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like PreciseDx in Health Care and New York
Companies Similar to PreciseDx
https://metriport.com
There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…
Serif Health provides healthcare price intelligence and contract management solution.
Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…
Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…
TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…
Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.
Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…
Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s…
Happy Health is a mission-driven technology company committed to transforming mental health awareness through…
Leal Therapeutics creates new treatments for patients.
Teal Health is on a mission to empower women when it comes to their health – starting with at-home cervical…
PreciseDx Funding FAQs
What does PreciseDx do?
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by analyzing morphology features. This allows for more tailored treatment and improved outcomes for patients. Clinical teams can trust PreciseDx for valuable insights and practical information to guide treatment choices. By utilizing artificial intelligence and its Morphology Feature Array™, PreciseDx designs disease-specific tests that provide in-depth pathology information and risk profiles for patients, aiding in treatment decisions.
How much funding has PreciseDx raised?
PreciseDx has raised $31.9M across 2 rounds on record. The most recent is a Series B of $11.2M announced in Jun 2025.
When did PreciseDx last raise funding?
PreciseDx's most recent funding round on record is a Series B of $11.2M, announced in Jun 2025.
Who founded PreciseDx?
FundedIQ lists Jack Zeineh (Founder), Michael J. Donovan (Founder) at PreciseDx.
Where is PreciseDx headquartered?
PreciseDx is based in New York, United States.
How many employees does PreciseDx have?
PreciseDx is in the 11-50 employee band.
How does PreciseDx's funding compare to other Health Care startups?
PreciseDx's latest round of $11.2M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's PreciseDx Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for PreciseDx is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.